InspireMD eliminates CCO role; Shane Gleason to depart July 31, 2026

InspireMD, Inc.

Shane Gleason, Chief Commercial Officer, notified on July 23, 2026 that his position is eliminated.
His last day of employment with InspireMD will be July 31, 2026.
No replacement for the CCO role has been announced.

item 5.02 item 9.01

InspireMD, Inc. filing history →

Source: SEC EDGAR

accession 0001493152-26-035220

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.